Found 17 matching trials
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
PHASE3This is an open-label extension study to Study 200622.In this study subject...
Location
GSK Investigational Site
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
PHASE4The purpose of this study is to investigate the feasibility of extending th...
Location
Dept of otorhinolaryngology, Aalborg University Hospital
Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300
N/AOBJECTIVES The primary objective of this study is evaluating the reduction ...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Immunological Basis for Mepolizumab Activity in COPD
PHASE2The current literature suggests that the mode of action of mepolizumab is t...
Location
Multiple Locations
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps
PHASE4The goal of this randomized clinical trial is to compare the effects of two...
Status
Active Not Recruiting
Location
Aalborg Universitetssygehus Syd
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
PHASE3The purpose of this study is to investigate the efficacy and safety of mepo...
Location
GSK Investigational Site
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
PHASE3Mepolizumab is a humanized monoclonal antibody. In conditions where eosinop...
Location
GSK Investigational Site
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
PHASE2Background:
Hypereosinophilic syndrome (HES) is a blood disorder that caus...
Location
National Institutes of Health Clinical Center
Effect of Mepolizumab on Severe Eosinophilic Asthma
N/ATwo parts: A:Case-control study including 15 healthy adult donors and 15 se...
Location
Complejo Hospitalario Universitario de Ferrol
Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)
N/AThis observational study aims to evaluate the long-term effectiveness and s...
Location
University of Florence